Home biosciences
 

Keywords :   


Tag: biosciences

Valent BioSciences Corporation Unveils its State-of-the-Art...

2014-06-28 11:57:54| Chemicals - Topix.net

Valent BioSciences Corporation today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel.

Tags: corporation unveils biosciences valent

 

Sofie Biosciences Partners with PerkinElmer to Deliver Benchtop PET in Vivo Imaging Systems to ...

2014-06-13 06:00:00| Industrial Newsroom - All News for Today

Preclinical PET Imaging Instruments in Benchtop Format Help Support High Performance Disease Research, Drug Discovery and Clinical Translational Applications<br /> <br /> CULVER CITY, Calif. &ndash; Sofie Biosciences, a leader in the field of PET imaging, and PerkinElmer Inc., today announced an agreement in which PerkinElmer will exclusively commercialize and sell preclinical Positron Emission Tomography (PET) - X-Ray and 3-dimensional Computed Tomography (CT) imaging systems developed by, or ...This story is related to the following:Medical Imaging Systems | Diagnostic Imaging Equipment |

Tags: to systems partners pet

 
 

Ambit Biosciences' (AMBI) CEO Mike Martino on Q1 2014 Results - Earnings Call Transcript

2014-05-07 07:23:08| Logistics - Topix.net

Welcome to the First Quarter 2014 Earnings Conference Call. My name is Bekiva, and I will be your operator for today's call.

Tags: results call mike ceo

 

Fluxion Biosciences Introduces IsoFlux NGS Assay Kits For Circulating Biomarker Detection

2014-04-30 06:48:03| drugdiscoveryonline News Articles

Fluxion Biosciences announced the introduction of a new series of assay kits design to enhance and complete the workflow for next-generation sequencing (NGS) using the IsoFlux System

Tags: kits detection introduces assay

 

Aastrom Biosciences Acquires Sanofi's Cell Therapy and Regenerative Medicine Business

2014-04-21 22:59:52| Biotech - Topix.net

Aastrom Biosciences , a developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, reported that it has entered into an agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine business for $6.5 million, with $4 million payable in cash at closing and $2.5 million payable ... (more)

Tags: business cell medicine therapy

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »